Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Guardant Health Inc’s stock clocked out at $102.02, down -5.99% from its previous closing price of $108.52. In other words, the price has decreased by -$5.99 from its previous closing price. On the day, 3.75 million shares were traded. GH stock price reached its highest trading level at $108.84 during the session, while it also had its lowest trading level at $100.675.
Ratios:
To gain a deeper understanding of GH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.12 and its Current Ratio is at 3.50.
On September 25, 2025, Wolfe Research Upgraded its rating to Outperform which previously was Peer Perform but kept the price unchanged to $75.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 05 ’25 when Freeman Chris bought 31,452 shares for $103.07 per share.
CLARK IAN T bought 28,611 shares of GH for $3,066,818 on Dec 05 ’25. On Dec 05 ’25, another insider, Bell Michael Brian, who serves as the Officer of the company, bought 80,362 shares for $103.14 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 13249787904 and an Enterprise Value of 13605074944. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.62. Its current Enterprise Value per Revenue stands at 15.074 whereas that against EBITDA is -33.827.
Stock Price History:
The Beta on a monthly basis for GH is 1.58, which has changed by 1.8050592 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, GH has reached a high of $112.43, while it has fallen to a 52-week low of $29.91. The 50-Day Moving Average of the stock is 21.86%, while the 200-Day Moving Average is calculated to be 78.84%.
Shares Statistics:
It appears that GH traded 2.67M shares on average per day over the past three months and 2180960 shares per day over the past ten days. A total of 125.01M shares are outstanding, with a floating share count of 124.15M. Insiders hold about 4.04% of the company’s shares, while institutions hold 96.59% stake in the company. Shares short for GH as of 1763078400 were 8955320 with a Short Ratio of 3.36, compared to 1760486400 on 8273789. Therefore, it implies a Short% of Shares Outstanding of 8955320 and a Short% of Float of 7.22.
Earnings Estimates
. The current market rating for Guardant Health Inc (GH) reflects the collective analysis of 15.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.29 and low estimates of -$0.6.
Analysts are recommending an EPS of between -$1.73 and -$1.91 for the fiscal current year, implying an average EPS of -$1.79. EPS for the following year is -$1.43, with 17.0 analysts recommending between -$0.89 and -$2.31.
Revenue Estimates
In. The current quarter, 19 analysts expect revenue to total $267.6M. It ranges from a high estimate of $270M to a low estimate of $264.6M. As of. The current estimate, Guardant Health Inc’s year-ago sales were $201.81MFor the next quarter, 19 analysts are estimating revenue of $271M. There is a high estimate of $284.1M for the next quarter, whereas the lowest estimate is $255.92M.
A total of 23 analysts have provided revenue estimates for GH’s current fiscal year. The highest revenue estimate was $970.1M, while the lowest revenue estimate was $965.3M, resulting in an average revenue estimate of $968.42M. In the same quarter a year ago, actual revenue was $739.02MBased on 22 analysts’ estimates, the company’s revenue will be $1.23B in the next fiscal year. The high estimate is $1.32B and the low estimate is $1.16B.
